$UHS

Universal Health Services (UHS) reported Q3 earnings of $5.22 per share, beating estimates by $0.02, with revenue up 5.3% YoY to $4.73B. Shares fell 3% after-hours due to legal settlement costs and Medicaid payment uncertainties. The quarter included a $26M charge for a tentative settlement in Cumberland Hospital litigation, partially offset by a $21M Medicaid payment benefit. UHS repurchased 1.35M shares at $242.1M.

UNIVERSAL HEALTH SERVICES INC (UHS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE October 27, 2026 CONTACT: Darren Lehrich Vice President-Investor Relations 610-382-3310 Darren.Lehrich@uhsinc.com UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2026 Consolida

Universal Health Services (UHS) reported Q3 EPS of $5.22, beating estimates by $0.02, with revenue at $4.73B, exceeding expectations. The stock is up 5.27% in 3 months but down 19.15% in 12 months. InvestingPro rates its financial health as 'great performance'.

Universal Health Services (UHS) shares dropped 6% after rival HCA Healthcare reported Q3 earnings beat but guided 2027 earnings to be flat, citing coverage losses and Medicaid payment declines. HCA's stock fell 4%. Analysts expect UHS to grow 2027 EPS by 6%, but this may be at risk. UHS reports Q3 earnings after market close.

HCA Healthcare (HCA) reported Q2 revenue of $20.23B, up 8.7% YoY, exceeding estimates by 2.4%. Tenet Healthcare (THC) saw revenue of $5.63B, up 6.8%, beating estimates by 3.9%. Universal Health Services (UHS) reported $4.64B, up 8.3%, exceeding estimates by 1.1%. Acadia Healthcare (ACHC) reported $865.8M, flat YoY, topping estimates by 2%. HCA and Tenet stocks rose 24.5% and 34.3% post-earnings, respectively, while Acadia fell 5%.

Cantor Fitzgerald maintained a Neutral rating on Universal Health Services (UHS) with a $194 price target. The firm noted mixed trends in staffing and labor costs, but strong financial health. Analysts have varying views on UHS, with some lowering price targets due to earnings misses and margin pressures, while others remain optimistic about its growth prospects and debt management.

The FTC sent letters to 24 major healthcare companies, including HCA Healthcare, Tenet Healthcare, Community Health Systems, and Universal Health Services, warning them to provide accurate and timely pricing information to patients. The FTC emphasized that deceptive pricing practices are prohibited, and companies must comply with transparency regulations.

Cantor Fitzgerald kept a Neutral rating on Universal Health Services (UHS) with a $194 price target. UHS trades at $175.07, below its Fair Value estimate. A survey showed worsening 2026 profit outlooks. Q2 revenue beat estimates at $4.64B, but EPS missed at $5.35. Analysts have mixed views on UHS's outlook and price targets.

Major for-profit health systems reported declines in surgical volumes in Q2 2026, citing insurance coverage reductions and consumer price consciousness. HCA, UHS, CHS, and Tenet Health all saw decreases, but executives remain optimistic about long-term demand. HCA's CEO noted potential easing of consumer sentiment in Q4. Companies are investing in outpatient capacity to meet future demand.

Analysts covering Universal Health Services (UHS) have a consensus rating of 'Moderate Buy,' with six 'Strong Buy' ratings, 13 'Holds,' and one 'Moderate Sell.' The sentiment has shifted from seven 'Moderate Buy' ratings two months ago. RBC Capital analyst Ben Hendrix maintained a 'Sector-Perform' rating, lowering the price target to $183 from $190, implying a 7.3% upside. The mean price target is $192.24, a 9% premium to the current price, while the highest target is $290, suggesting a 64.4% up